Product
Refralon
1 clinical trial
3 indications
Indication
AFibIndication
Atrial FibrillationIndication
Atrial flutterClinical trial
Retrospective Registry for the Efficacy and Safety Evaluation of Refralon®, Concentrate for Solution for Intravenous Injection in Patients With Paroxysmal and Persistent Atrial Fibrillation and FlutterStatus: Completed, Estimated PCD: 2023-06-01